List your tool

Head to head · 2026

Proscia vs Viz.ai

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

Proscia

FDA-cleared digital pathology platform for primary diagnosis and biomarker research

4.3Not listed

Visit Proscia (opens Proscia in a new tab)

Viz.ai

Trusted by 2,000+ hospitals, cutting stroke transfer time by 44% in 2026 clinical data

4.4Not listed

Visit Viz.ai (opens Viz.ai in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: Proscia does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    Viz.ai

    4.3 against 4.4

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onProsciaViz.ai
Our rating4.34.4Better
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • FDA-cleared for primary clinical diagnosis in AP-Dx
  • Concentriq AP, AP-Dx and LS configurations
  • Biomarker research and clinical trial workflows
  • Cloud deployment
  • Predetermined Change Control Plan for regulatory compliance
  • First FDA-cleared AI platform for stroke triage and large vessel occlusion detection
  • Alerts the entire care team simultaneously rather than one reader at a time
  • Trusted by more than 2,000 hospitals across the United States
  • #1 AI-powered clinical decision support platform, 2026 Black Book survey
  • 44% reduction in door-in-door-out time shown in 2026 clinical data
Pros
  • FDA clearance for primary diagnosis, not just research viewing
  • Deployed across 4,000 hospitals and 16 of the top 20 pharma companies
  • Rated highest in KLAS 2026 in both the US and Europe
  • Pioneered FDA-cleared AI stroke triage with a long clinical track record
  • Simultaneous care-team alerting addresses coordination, not just detection speed
  • Massive hospital network, 2,000+, gives strong real-world validation
Cons
  • No published pricing
  • Requires compatible scanning hardware
  • Adoption is a laboratory-wide programme, not a purchase
  • Enterprise pricing requires a sales conversation, no published self-serve rate
  • Built specifically for time-critical conditions like stroke, a narrow clinical scope
  • Best suited to hospitals with the imaging infrastructure to support real-time triage
CompanyProscia Inc.Viz.ai, founded 2016

Prices come from each vendor's pricing page, last checked 20260814. Check the vendor before you buy.

FAQ

Questions people ask

Is Proscia better than Viz.ai?

In our reviews Proscia scores 4.3 and Viz.ai scores 4.4. The better pick depends on the job. Proscia: FDA-cleared digital pathology platform for primary diagnosis and biomarker research. Viz.ai: Trusted by 2,000+ hospitals, cutting stroke transfer time by 44% in 2026 clinical data.

Which is cheaper, Proscia or Viz.ai?

Proscia: see pricing. Viz.ai: see pricing.

Do Proscia and Viz.ai have free plans?

Neither lists a free plan.

More comparisons